184 related articles for article (PubMed ID: 31841883)
1. The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.
Pan XB; Li L; Qu S; Chen L; Liang SX; Zhu XD
Oral Oncol; 2020 Feb; 101():104520. PubMed ID: 31841883
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
4. Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma.
Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
Clin Otolaryngol; 2021 Jul; 46(4):802-808. PubMed ID: 33580628
[TBL] [Abstract][Full Text] [Related]
5. Significance of chemotherapy for older patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A propensity score matching analysis.
Chen J; Ding J; Xu Y; Hong H; Lin X; Xu M; Yan L; Xu T; Fei Z; Chen C
J Geriatr Oncol; 2023 Nov; 14(8):101648. PubMed ID: 37897887
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
Xu YC; Chen KH; Liang ZG; Zhu XD
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
[TBL] [Abstract][Full Text] [Related]
7. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
[TBL] [Abstract][Full Text] [Related]
8. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
[TBL] [Abstract][Full Text] [Related]
10. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.
Guo R; Mao YP; Chen L; Tang LL; Zhou GQ; Liu LZ; Tian L; Zeng MS; Jia WH; Shao JY; Lin AH; Ma J
Oncotarget; 2017 Feb; 8(6):10594-10601. PubMed ID: 27070084
[TBL] [Abstract][Full Text] [Related]
11. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
Sun J; Huang Z; Hu Z; Sun R
J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.
Luo HD; Xia FJ; Wu JH; Yi B
Oral Oncol; 2022 Aug; 131():105927. PubMed ID: 35679694
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
15. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it.
Qu W; Wang X; Qiao Q; Wang Y
Cancer Med; 2023 Mar; 12(6):6994-7004. PubMed ID: 36494918
[TBL] [Abstract][Full Text] [Related]
17. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Zhang LN; Gao YH; Lan XW; Tang J; Su Z; Ma J; Deng W; OuYang PY; Xie FY
Oncotarget; 2015 Dec; 6(41):44019-29. PubMed ID: 26528755
[TBL] [Abstract][Full Text] [Related]
18. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
Verma V; Allen PK; Simone CB; Gay HA; Lin SH
J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
[No Abstract] [Full Text] [Related]
19. Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma: A SEER population-based study.
Lu Y; Hua J; Yan F; Jiang C; Piao Y; Ye Z; Fu Z; Jiang H; Wang F; Jiang Y
Medicine (Baltimore); 2021 Jul; 100(29):e26629. PubMed ID: 34398019
[TBL] [Abstract][Full Text] [Related]
20. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
